BridgeBio Pharma

+$0.35 (+0.71%) Today

$0.00 (0.00%) As of 8:01 AM UTC after-hours

Why Robinhood?

You can buy or sell BBIO and other stocks, options, and ETFs commission-free!

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO

Neil Kumar

Employees

385

Headquarters

Palo Alto, California

Founded

2015

BBIO Key Statistics

Market Cap

7.22B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

853.61K

High Today

$51.28

Low Today

$48.42

Open Price

$48.53

Volume

867.37K

52 Week High

$73.50

52 Week Low

$26.17

Analyst Ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

BBIO Earnings

-$1.18

-$0.79

-$0.39

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.80 per share

Actual

-$1.18 per share